302 related articles for article (PubMed ID: 15063228)
1. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
[TBL] [Abstract][Full Text] [Related]
2. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.
Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G
Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227
[TBL] [Abstract][Full Text] [Related]
3. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
4. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases.
Veronesi G; Morandi U; Alloisio M; Terzi A; Cardillo G; Filosso P; Rea F; Facciolo F; Pelosi G; Gandini S; CalabrĂ² F; Casali C; Marulli G; Spaggiari L
Lung Cancer; 2006 Jul; 53(1):111-5. PubMed ID: 16697073
[TBL] [Abstract][Full Text] [Related]
5. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age.
Matsuoka H; Okada M; Sakamoto T; Tsubota N
Eur J Cardiothorac Surg; 2005 Sep; 28(3):380-3. PubMed ID: 16054820
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity.
Iyoda A; Hiroshima K; Moriya Y; Mizobuchi T; Otsuji M; Sekine Y; Shibuya K; Iizasa T; Saitoh Y; Fujisawa T
Ann Thorac Surg; 2004 Jun; 77(6):1891-5; discussion 1895. PubMed ID: 15172230
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis of surgically treated large cell neuroendocrine carcinoma].
Matsuura N; Nakashima N; Igai H; Tarumi S; Chang SS; Misaki N; Liu D; Go T; Ishikawa S; Huang CL; Yokomise H
Kyobu Geka; 2011 Mar; 64(3):187-90. PubMed ID: 21404553
[TBL] [Abstract][Full Text] [Related]
9. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
Ab' Saber AM; Massoni Neto LM; Bianchi CP; Ctenas BB; Parra ER; Eher EM; Pereira JC; Takagaki T; Yamaguchi NH; Capelozzi VL
Ann Thorac Surg; 2004 Jun; 77(6):1883-90. PubMed ID: 15172229
[TBL] [Abstract][Full Text] [Related]
12. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
13. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
[TBL] [Abstract][Full Text] [Related]
14. Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.
Mitchell JD; Mathisen DJ; Wright CD; Wain JC; Donahue DM; Allan JS; Moncure AC; Grillo HC
J Thorac Cardiovasc Surg; 2001 Mar; 121(3):465-71. PubMed ID: 11241081
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
16. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
[TBL] [Abstract][Full Text] [Related]
18. Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide.
Filosso PL; Ruffini E; Oliaro A; Rena O; Casadio C; Mancuso M; Turello D; Cristofori RC; Maggi G
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):819-24. PubMed ID: 15821649
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic evaluation.
Selvakumar E; Rajendran S; Balachandar TG; Kannan DG; Jeswanth S; Ravichandran P; Surendran R
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):422-5. PubMed ID: 18693180
[TBL] [Abstract][Full Text] [Related]
20. [Neuroendocrine tumors of the lung].
Oliaro A; Donati G; Filosso PL; Ruffini E
Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]